Next Article in Journal
Previous Article in Journal
J. Pers. Med. 2013, 3(3), 144-176; doi:10.3390/jpm3030144
Review

Antisense Therapy in Neurology

1
 and 1,2,*
Received: 27 May 2013; in revised form: 26 July 2013 / Accepted: 29 July 2013 / Published: 2 August 2013
View Full-Text   |   Download PDF [911 KB, updated 12 August 2013; original version uploaded 2 August 2013]   |   Browse Figures
Abstract: Antisense therapy is an approach to fighting diseases using short DNA-like molecules called antisense oligonucleotides. Recently, antisense therapy has emerged as an exciting and promising strategy for the treatment of various neurodegenerative and neuromuscular disorders. Previous and ongoing pre-clinical and clinical trials have provided encouraging early results. Spinal muscular atrophy (SMA), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy (DMD), Fukuyama congenital muscular dystrophy (FCMD), dysferlinopathy (including limb-girdle muscular dystrophy 2B; LGMD2B, Miyoshi myopathy; MM, and distal myopathy with anterior tibial onset; DMAT), and myotonic dystrophy (DM) are all reported to be promising targets for antisense therapy. This paper focuses on the current progress of antisense therapies in neurology.
Keywords: Duchenne muscular dystrophy (DMD); Fukuyama congenital muscular dystrophy (FCMD); myotonic dystrophy (DM); spinal muscular atrophy (SMA); Huntington’s disease (HD); amyotrophic lateral sclerosis (ALS); limb-girdle muscular dystrophy 2B (LGMD2B); Miyoshi myopathy (MM); distal myopathy with anterior tibial onset (DMAT); antisense therapy Duchenne muscular dystrophy (DMD); Fukuyama congenital muscular dystrophy (FCMD); myotonic dystrophy (DM); spinal muscular atrophy (SMA); Huntington’s disease (HD); amyotrophic lateral sclerosis (ALS); limb-girdle muscular dystrophy 2B (LGMD2B); Miyoshi myopathy (MM); distal myopathy with anterior tibial onset (DMAT); antisense therapy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Lee, J.J.A.; Yokota, T. Antisense Therapy in Neurology. J. Pers. Med. 2013, 3, 144-176.

AMA Style

Lee JJA, Yokota T. Antisense Therapy in Neurology. Journal of Personalized Medicine. 2013; 3(3):144-176.

Chicago/Turabian Style

Lee, Joshua J.A.; Yokota, Toshifumi. 2013. "Antisense Therapy in Neurology." J. Pers. Med. 3, no. 3: 144-176.

J. Pers. Med. EISSN 2075-4426 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert